Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 1
2006 8
2007 2
2009 4
2010 2
2012 1
2013 4
2014 2
2015 3
2016 4
2017 3
2018 1
2019 1
2020 2
2021 1
2022 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Aberrant DNA methylation in contrast with mutations.
Ushijima T, Asada K. Ushijima T, et al. Among authors: asada k. Cancer Sci. 2010 Feb;101(2):300-5. doi: 10.1111/j.1349-7006.2009.01434.x. Epub 2009 Nov 13. Cancer Sci. 2010. PMID: 19958364 Free article. Review.
Clinical Significance of Serum Zinc Levels on the Development of Sarcopenia in Cirrhotic Patients.
Murata K, Namisaki T, Fujimoto Y, Takeda S, Enomoto M, Takaya H, Tsuji Y, Shibamoto A, Suzuki J, Kubo T, Iwai S, Tomooka F, Tanaka M, Kaneko M, Asada S, Koizumi A, Yorioka N, Matsuda T, Ozutsumi T, Ishida K, Ogawa H, Takagi H, Fujinaga Y, Furukawa M, Sawada Y, Nishimura N, Kitagawa K, Sato S, Kaji K, Inoue T, Asada K, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Murata K, et al. Among authors: asada k. Cancer Diagn Progn. 2022 Mar 3;2(2):184-193. doi: 10.21873/cdp.10093. eCollection 2022 Mar-Apr. Cancer Diagn Progn. 2022. PMID: 35399181 Free PMC article.
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
Namisaki T, Kaji K, Shimozato N, Kaya D, Ozutsumi T, Tsuji Y, Fujinaga Y, Kitagawa K, Furukawa M, Sato S, Sawada Y, Nishimura N, Takaya H, Okura Y, Seki K, Kawaratani H, Moriya K, Noguchi R, Asada K, Akahane T, Mitoro A, Yoshiji H. Namisaki T, et al. Among authors: asada k. Indian J Gastroenterol. 2022 Apr;41(2):169-180. doi: 10.1007/s12664-021-01220-5. Epub 2022 Mar 12. Indian J Gastroenterol. 2022. PMID: 35279807
Combination of a synthetic retinoid and a DNA demethylating agent induced differentiation of neuroblastoma through retinoic acid signal reprogramming.
Hattori N, Asada K, Miyajima N, Mori A, Nakanishi Y, Kimura K, Wakabayashi M, Takeshima H, Nitani C, Hara J, Ushijima T. Hattori N, et al. Among authors: asada k. Br J Cancer. 2021 Dec;125(12):1647-1656. doi: 10.1038/s41416-021-01571-y. Epub 2021 Oct 11. Br J Cancer. 2021. PMID: 34635821 Free PMC article.
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis.
Suzuki J, Namisaki T, Takya H, Kaji K, Nishimura N, Shibamoto A, Asada S, Kubo T, Iwai S, Tomooka F, Takeda S, Koizumi A, Tanaka M, Matsuda T, Inoue T, Fujimoto Y, Tsuji Y, Fujinaga Y, Sato S, Kitagawa K, Kawaratani H, Akahane T, Mitoro A, Matsumoto M, Asada K, Yoshiji H. Suzuki J, et al. Among authors: asada k. Int J Mol Sci. 2024 Feb 26;25(5):2678. doi: 10.3390/ijms25052678. Int J Mol Sci. 2024. PMID: 38473925 Free PMC article.
Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosis.
Shimozato N, Namisaki T, Kaji K, Kitade M, Okura Y, Sato S, Moriya K, Seki K, Kawaratani H, Takaya H, Sawada Y, Saikawa S, Nakanishi K, Furukawa M, Fujinaga Y, Kubo T, Asada K, Kitagawa K, Tsuji Y, Kaya D, Ozutsumi T, Akahane T, Mitoro A, Yoshiji H. Shimozato N, et al. Among authors: asada k. Hepatol Res. 2019 Oct;49(10):1147-1161. doi: 10.1111/hepr.13385. Epub 2019 Jul 15. Hepatol Res. 2019. PMID: 31177586
44 results